While TOP1 mutations were rare in ovarian cancer cell lines and tumors, a subset of ovarian cancers had dysregulated expression levels of TOP1. The correlation with poor survival suggests a mechanism of resistance to DNA damaging chemotherapy, since the patient tumors were taken at the time of initial diagnosis. This evidence concerns the gene TOP1 and ovarian cancer.